CLRB
USDCellectar Biosciences Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$3.490
Máximo
$3.560
Mínimo
$3.465
Volume
0.02M
Fundamentos da empresa
Capitalização de mercado
11.2M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.19M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
FLORHAM PARK, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
FLORHAM PARK, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB) ("Cellectar" or the "company"), a late-stage biotechnology company focused on the discovery and development of drugs for
Ações relacionadas
TMHC
Taylor Morrison Home Corporation
ECCV
Eagle Point Credit Company Inc. 5.375% Notes due 2029
QSIAW
Quantum-Si Incorporated Warrant
FGB
First Trust Specialty Finance and Financial Opportunities Fund
FSHPU
Flag Ship Acquisition Corp. Unit
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.